Results 111 to 120 of about 153,640 (335)

Association Between Cardiometabolic Index and Blood Pressure: A Cross-Sectional Analysis of the NHANES 2015–2018 Data

open access: yesReviews in Cardiovascular Medicine
Background: Hypertension is a major risk factor for cardiovascular diseases (CVDs) and is closely related to metabolic abnormalities.
Lingyan He   +3 more
doaj   +1 more source

Measured exposures to glyphosate in applicators and the general population: an updated review of the scientific literature since 2020

open access: yesPest Management Science, EarlyView.
This update examines exposure information for glyphosate in applicators and the general population published since 2020. The overall conclusions from these studies are that margins of exposure for applicators have not decreased since 2020 and still present de minimis risk.
Keith R. Solomon
wiley   +1 more source

Exploration of the association between estimated glucose disposal rate and osteoarthritis in middle-aged and older adults: An analysis of NHANES data from 2011 to 2018

open access: yesOpen Medicine
It is unclear how the estimated glucose disposal rate (eGDR) index relates to osteoarthritis (OA). The goal of this research is to explore the possible link between the eGDR index and the likelihood of OA development.
Gu XiaoPeng, Zhang SongOu, Ma WeiHu
doaj   +1 more source

Conicity Index Associated with Adult Hearing Impairment: A Cross-Sectional Study Based on the National Health and Nutrition Examination Survey (2001–2018)

open access: yesNoise and Health
Objective: This study aimed to evaluate the association of conicity index (C-index), a marker of abdominal obesity, with hearing impairment (HI) in US adults using data from the National Health and Nutrition Examination Survey (NHANES).
Guifen Cai   +3 more
doaj   +1 more source

MAFLD Criteria Guide the Subtyping of Patients with Fatty Liver Disease

open access: yesRisk Management and Healthcare Policy, 2021
Jiaofeng Huang,1 Weijie Ou,1 Mingfang Wang,1 Medha Singh,2 Yuxiu Liu,1 Shiying Liu,1 Yinlian Wu,1 Yueyong Zhu,1,3 Rahul Kumar,4,* Su Lin1,* 1Department of Hepatology, Hepatology Research Institute, The First Affiliated Hospital, Fujian Medical University,
Huang J   +9 more
doaj  

Hypertension and Renal Dysfunction [PDF]

open access: yesJournal of the American Society of Nephrology, 2003
The incidence rate of end-stage renal disease has increased in many countries in the past 20 yr, including the United States and Singapore. The increase in ESRD incidence in the United States is primarily attributable to diabetes and to hypertension.
openaire   +3 more sources

A Novel Empirical Autoinduction Model to Characterize the Population Pharmacokinetics and Recommend Dose for Repotrectinib in Adult and Adolescents With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1‐3 Rearrangements

open access: yesCPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Repotrectinib is approved in the US for treating ROS1‐positive non‐small cell lung cancer (NSCLC) and solid tumors harboring an NTRK gene fusion. A Population Pharmacokinetic (PopPK) model for repotrectinib was developed using data from 620 adults (118 healthy volunteers and 502 patients) across seven studies and 24 pediatric patients from one
Shengnan Du   +8 more
wiley   +1 more source

Risk Indicators for Periodontitis in US Adults: NHANES 2009 to 2012.

open access: yesThe Journal of Periodontology, 2016
BACKGROUND Through the use of optimal surveillance measures and standard case definitions, it is now possible to more accurately determine population-average risk profiles for severe (SP) and non-severe periodontitis (NSP) in adults (aged 30 years and ...
P. Eke   +6 more
semanticscholar   +1 more source

Weight Control Strategies and Diet Quality [PDF]

open access: yes
obesity, diet quality, nhanes, Consumer/Household Economics, Food Consumption/Nutrition/Food Safety, I00,
Gao, Zhifeng   +2 more
core   +1 more source

Population Pharmacokinetics Modeling of Selpercatinib to Support Posology in Pediatric Patients With RET‐Altered Metastatic Thyroid Cancer or Solid Tumors

open access: yesCPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Selpercatinib is a first‐in‐class, highly selective, RET kinase inhibitor with CNS activity, approved for the treatment of RET‐altered lung, thyroid, and other cancers. We report pharmacokinetic analyses to identify factors affecting selpercatinib steady‐state exposure and support posology in pediatric patients.
Dan Liu, Jan‐Stefan van der Walt
wiley   +1 more source

Home - About - Disclaimer - Privacy